Efficacy and safety of polyherbal formulation as an add-on to standard-of-care in mild-to-moderate COVID-19: A randomized, double-blind, placebo-controlled trial

BACKGROUND: Novel corona virus disease-2019 (COVID-19) pandemic is a significant contributor to morbidity and mortality in affected individuals. Modulating the immune response in COVID-19 is now an established treatment approach. Polyherbal formulations have long been assessed for their potential im...

Descripción completa

Detalles Bibliográficos
Autores principales: Patankar, Suresh B., Gorde, Anupama, Joshi, Kalpana, Suryawanshi, Kishor, Soni, Pravin, Shah, Tejas, Patankar, Sagar, Jha, Diwakar, Raje, Rajesh, Rangnekar, Hrishikesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595378/
https://www.ncbi.nlm.nih.gov/pubmed/36311474
http://dx.doi.org/10.1016/j.jaim.2022.100653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595378/
https://www.ncbi.nlm.nih.gov/pubmed/36311474
http://dx.doi.org/10.1016/j.jaim.2022.100653

Ejemplares similares